|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 6
2018
Reuther, Clemens; Heinzle, Vera; Noelting, Svenja; Herterich, Sabine; Hahner, Stefanie; Halilovic, Ensar; Jeay, Sebastien; Wuerthner, Jens U.; Prada, Elke Tatjana Aristizabal; Spoettl, Gerald; Maurer, Julian und Auernhamme, Christoph J.
(2018):
The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53(wild type) Neuroendocrine Tumor Cell Line GOT1.
In: Neuroendocrinology, Bd. 106, Nr. 1: S. 1-19
Prada, Elke Tatjana Aristizabal; Noelting, Svenja; Spoettl, Gerald; Maurer, Julian und Auernhammer, Christoph Josef
(2018):
The Novel Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) Alone and in Dual-Targeting Approaches Demonstrates Antitumoral Efficacy in Neuroendocrine Tumors in vitro.
In: Neuroendocrinology, Bd. 106, Nr. 1: S. 58-73
Prada, Elke Tatjana Aristizabal; Heinzle, Vera; Knoesel, Thomas; Noelting, Svenja; Spoettl, Gerald; Maurer, Julian; Spitzweg, Christine; Angele, Martin; Schmidt, Nina; Beuschlein, Felix; Stalla, Guenter K.; Blaser, Rainer; Kuhn, Klaus A. und Auernhammer, Christoph J.
(2018):
Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors.
In: Endocrine-Related Cancer, Bd. 25, Nr. 5: S. 547-560
2017
Nölting, Svenja; Rentsch, Jakob; Freitag, Helma; Detjen, Katharina; Briest, Franziska; Möbs, Markus; Weissmann, Victoria; Siegmund, Britta; Auernhammer, Christoph J.; Prada, Elke Tatjana Aristizabal; Lauseker, Michael; Grossman, Ashley; Exner, Samantha; Fischer, Christian; Schrader, Jörg und Grabowski, Patricia
(2017):
The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
In: PLoS ONE 12(8), e0182852 [PDF, 8MB]
In: PLoS ONE 12(8), e0182852 [PDF, 8MB]
Prada, Elke Tatjana Aristizabal; Orth, Michael; Nölting, Svenja; Spöttl, Gerald; Maurer, Julian und Auernhammer, Christoph
(2017):
The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells.
In: PLOS One 12(5), e0178375 [PDF, 15MB]
In: PLOS One 12(5), e0178375 [PDF, 15MB]
2015
Noelting, Svenja; Maurer, Julian; Spoettl, Gerald; Prada, Elke Tatjana Aristizabal; Reuther, Clemens; Young, Karen; Korbonits, Marta; Goeke, Burkhard; Grossman, Ashley und Auernhammer, Christoph J.
(2015):
Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways.
In: PLOS ONE 10(12), e0143830 [PDF, 3MB]
In: PLOS ONE 10(12), e0143830 [PDF, 3MB]